Featured
The new facility will focus on key areas including discovery chemistry, drug metabolism and pharmacokinetics, Genome Valley, Precision Medicine and data, technology and digital innovation. The centre is expected to strengthen Amgen’s research capabilities while supporting the development of advanced approaches to drug discovery and healthcare innovation.According to the Telangana government, the proposed centre is expected to create employment opportunities for around 200 highly skilled professionals, further strengthening Hyderabad’s position as a global life sciences and research hub.The expansion builds on Amgen’s existing presence in the city, including its global capability centre established in 2025, and reflects the company’s continued investment in Hyderabad’s growing scientific and technology ecosystem.
The Bigger Picture
The move highlights Hyderabad’s growing importance as a destination for global pharmaceutical R&D, precision medicine and technology-led life sciences innovation.
Amgen’s investment shows how global healthcare companies are increasingly combining scientific research with AI, digital technologies and data capabilities to accelerate innovation.
